Cold & Cough Remedies (Pharmacies) - Hong Kong

  • Hong Kong
  • Revenue in the Cold & Cough Remedies market is projected to reach US$250.70m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.98%, resulting in a market volume of US$368.00m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$33.45 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Hong Kong is experiencing steady growth due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
In Hong Kong, customers have a strong preference for over-the-counter medications, including cold and cough remedies, which they can easily purchase at pharmacies without a prescription. This preference is driven by the convenience and accessibility of these products, as well as the trust that customers have in the quality and effectiveness of over-the-counter medications. Additionally, customers in Hong Kong value products that provide quick relief from cold and cough symptoms, such as nasal congestion, sore throat, and coughing.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Hong Kong is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking products that are perceived as being safer and more natural. This trend is driven by a growing awareness of the potential side effects of certain pharmaceutical drugs and a desire for more holistic approaches to healthcare. As a result, pharmacies in Hong Kong are expanding their product offerings to include a wider range of natural and herbal remedies for cold and cough relief. Another trend in the market is the growing popularity of online pharmacies. Customers in Hong Kong are increasingly turning to online platforms to purchase cold and cough remedies, as well as other healthcare products. This trend is fueled by the convenience and ease of online shopping, as well as the availability of a wider range of products compared to traditional brick-and-mortar pharmacies. Online pharmacies also often offer competitive prices and discounts, which further attracts customers.

Local special circumstances:
Hong Kong's high population density and busy lifestyle contribute to the demand for cold and cough remedies. The city's crowded public transportation system and close proximity of individuals in public spaces increase the risk of spreading infectious diseases, such as the common cold and flu. As a result, customers in Hong Kong are more likely to seek remedies to alleviate their symptoms and prevent the spread of illness. Additionally, the city's hot and humid climate can exacerbate cold and cough symptoms, leading to a higher demand for relief products.

Underlying macroeconomic factors:
Hong Kong's strong economy and high disposable income levels contribute to the growth of the Cold & Cough Remedies (Pharmacies) market. The city's residents have the financial means to purchase over-the-counter medications and are willing to spend on products that provide relief from cold and cough symptoms. Additionally, Hong Kong's well-developed healthcare system and access to quality healthcare services ensure that customers have the necessary information and resources to manage their cold and cough symptoms effectively. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Hong Kong is driven by customer preferences for over-the-counter medications, trends towards natural and herbal remedies, the popularity of online pharmacies, local special circumstances such as high population density and a hot climate, and underlying macroeconomic factors including a strong economy and high disposable income levels. These factors contribute to the steady growth of the market and the continued demand for cold and cough remedies in Hong Kong.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)